Michael A. DesJardin is VP at Horizon Therapeutics Public Ltd Co (HZNP). They have made 8 open-market trades across 1 company since 2020, most recently 2023-10-06.
CIK 0001512985
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HZNP | SELL | 2022-04-12 | 2022-04-14 | $113.12 | $4.6M | -10.9% | -21.3% | -29.5% |
| HZNP | SELL | 2022-03-02 | 2022-03-04 | $97.19 | $6.8M | +5.4% | +8.4% | -6.7% |
| HZNP | SELL | 2021-02-24 | 2021-02-26 | $91.25 | $2.1M | -2.8% | -12.6% | +0.3% |
| HZNP | SELL | 2021-02-11 | 2021-02-12 | $90.00 | $971K | -0.6% | +1.5% | -3.7% |
| HZNP | SELL | 2021-02-02 | 2021-02-04 | $85.00 | $385K | +1.8% | +1.3% | +4.3% |
| HZNP | SELL | 2021-01-06 | 2021-01-08 | $75.00 | $2.0M | -1.3% | +12.8% | +16.0% |
| HZNP | SELL | 2020-12-10 | 2020-12-11 | $69.64 | $823K | -12.0% | +2.3% | +17.5% |
| HZNP | SELL | 2020-05-05 | 2020-05-07 | $40.59 | $1.5M | +11.0% | +17.7% | +83.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.